Detailed Information
Cited 1 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Venetoclax and azacitidine combination in chemotherapy ineligible untreated patients with therapy-related myeloid neoplasms, antecedent myelodysplastic syndromes, or myelodysplastic/myeloproliferative neoplasms.
- Authors
- Pullarkat, V[Pullarkat, Vinod]; Pratz, K[Pratz, Keith]; Dohner, H[Dohner, Hartmut]; Recher, C[Recher, Christian]; Thirman, MJ[Thirman, Michael J.]; Dinardo, CD[Dinardo, Courtney Denton]; Fenaux, P[Fenaux, Pierre]; Schuh, AC[Schuh, Andre C.]; Wei, AH[Wei, Andrew H.]; Pigneux, A[Pigneux, Arnaud]; Jang, JH[Jang, Jun Ho]; Juliusson, G[Juliusson, Gunnar]; Miyazaki, K[Miyazaki, Kazuhito]; Selleslag, D[Selleslag, Dominik]; Arellano, ML[Arellano, Martha Lucia]; Naqvi, K[Naqvi, Kiran]; Yu, J[Yu, Jun]; Ridgeway, J[Ridgeway, Jean]; Potluri, J[Potluri, Jalaja]; Konopleva, M[Konopleva, Marina]
- Issue Date
- 20-May-2021
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.39, no.15
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 39
- Number
- 15
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.